U.K. Pharmaceuticals & Biotech Top Stock Picks from Analysts

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Indivior

Market Cap: UK£879.6m

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Faron Pharmaceuticals Oy

Market Cap: UK£311.6m

Operates as a clinical stage drug discovery and development company.

PureTech Health

Market Cap: UK£301.2m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Oxford Biomedica

Market Cap: UK£295.7m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Allergy Therapeutics

Market Cap: UK£271.7m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

MaxCyte

Market Cap: UK£204.1m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Avacta Group

Market Cap: UK£152.9m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Animalcare Group

Market Cap: UK£146.9m

Develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally.

Bioventix

Market Cap: UK£127.9m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Scancell Holdings

Market Cap: UK£113.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

hVIVO

Market Cap: UK£110.6m

Operates as a pharmaceutical service and contract research company in the United Kingdom.

Diaceutics

Market Cap: UK£95.5m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

SkinBioTherapeutics

Market Cap: UK£47.8m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

ECO Animal Health Group

Market Cap: UK£36.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Futura Medical

Market Cap: UK£27.2m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Shield Therapeutics

Market Cap: UK£21.5m

A commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.

Arecor Therapeutics

Market Cap: UK£14.3m

A biopharmaceutical company, focuses on developing products in diabetes and other indications ion the United Kingdom.

Poolbeg Pharma

Market Cap: UK£13.5m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

IXICO

Market Cap: UK£7.3m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Verici Dx

Market Cap: UK£5.2m

Develops prognostic and diagnostic tests for kidney transplant patients.

Theracryf

Market Cap: UK£4.8m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.

LungLife AI

Market Cap: UK£275.9k

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.